↓ Skip to main content

Immunogenicity of pembrolizumab in patients with advanced tumors

Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy
1 policy source
twitter
9 X users
patent
3 patents

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
72 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunogenicity of pembrolizumab in patients with advanced tumors
Published in
Journal for Immunotherapy of Cancer, August 2019
DOI 10.1186/s40425-019-0663-4
Pubmed ID
Authors

Marianne J. H. van Vugt, Julie A. Stone, “Rik” H. J. M. M. De Greef, Ellen S. Snyder, Leslie Lipka, David C. Turner, Anne Chain, Mallika Lala, Mengyao Li, Seth H. Robey, Anna G. Kondic, Dinesh De Alwis, Kapil Mayawala, Lokesh Jain, Tomoko Freshwater

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 17%
Student > Ph. D. Student 9 13%
Student > Bachelor 9 13%
Unspecified 5 7%
Student > Master 4 6%
Other 9 13%
Unknown 24 33%
Readers by discipline Count As %
Medicine and Dentistry 11 15%
Biochemistry, Genetics and Molecular Biology 11 15%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Unspecified 5 7%
Agricultural and Biological Sciences 4 6%
Other 10 14%
Unknown 26 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2024.
All research outputs
#2,616,256
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#719
of 3,424 outputs
Outputs of similar age
#52,685
of 356,394 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#22
of 97 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,394 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.